0% found this document useful (0 votes)
814 views6 pages

Pharmacovigilance Answer-Key

Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
814 views6 pages

Pharmacovigilance Answer-Key

Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 6

FINAL YEAR UNIVERSITY EXAMINATION 2019-2020

Final Year B.Pharm. Semester VIII


SUBJECT-BPH_E_808_T-Pharmacovigilance
MULTIPLE CHOICE QUESTIONS: ANSWER KEY

SET 1

Q. No. Correct Option


1 A
2 A
3 C
4 A
5 B
6 B
7 A
8 D
9 B
10 A
11 D
12 D
13 D
14 C
15 D
16 C
17 D
18 B
19 B
20 C
21 B
22 C
23 C
24 A
25 C
26 D
27 A
28 A
29 B
30 B
31 D
32 C
33 B
34 C
35 B
FINAL YEAR UNIVERSITY EXAMINATION 2019-2020 (Regular Exam)
SUBJECT-BPH_E_808_T-PHARMACOVIGILANCE

SET 2

1. What is Pharmacovigilance

Ans:- C: Analyze the risk, safety of medicine

2. Who is responsible for WHO international drug monitoring Programme?

Ans :- A: Uppsala Monitoring Center

3. The functions of UMC are:

Ans :- D: Collecting, assessing and communicating information from member countries

4. The no of volunteers involved in phase I are -

Ans :- B: 20-80

5. CROs stand for:

Ans :- A: Contract research organizations

6. Pharmacovigilance programme of India was started by Govt of India on -

Ans :- B: 14th July 2010

7. The objectives of PVPI includes

Ans :- D: Create national wide system for patient safety reporting

8. Adverse drug reactions are

Ans :- B: Noxious and unintended response of drug at normal therapeutic dose

9. Type A adverse reactions are -

Ans :- C: Dose independent

10. Type B adverse reactions are -

Ans :- A: Dose independent

11. Delayed adverse reactions –

Ans :- B: Adverse event occurs after some time


12. Continuous drug use adverse reactions may be -

Ans :- A: Irreversible, unexpected

13. The most commonly adopted method for reporting of ADR is -

Ans :- C: Spontaneous reporting

14. What is the first step in management of ADR -

Ans :- C: Withdrawal of suspected drug

15. Management of ADR involves

Ans: - A: Symptomatic and specific treatment of suspected reaction

16. Naranjio scale method of causality assessment is -

Ans: - A: Algorithmic method

17. What is the meaning of highly probable ADR?

Ans :- B: If frequencies of ADR are more

18. Which one of the following in not true in infants, that may influence safety of drugs?

Ans: D: Less volume of distribution for hydrophilic drugs

19. Infants have lower renal clearance because:

Ans: B: GFR reaches adult levels by 2 years of age

20. A known limitation of spontaneous ADR reporting is:

Ans: A: Under reporting

21. Which of the following is special aspects of drugs in the elderly?

Ans: B: Increased hepatic metabolism capacity

22. Which of the following is not a possible pregnancy outcome?

Ans: D: Leukaemia

23. What is pre-term birth?


Ans: A: less than 37 completed

24. Following is the method of Pharmacovigilance

Ans :- B: Active surveillance

25. This is Passive Surveillance method -

Ans :- A: Spontaneous reports

26. Aims of spontaneous reporting are -

Ans :- B: Benefit risk analysis

27. Following is not a method of stimulated reposting

Ans :- C: Offline reporting

28. Sentinel meaning -

Ans :- B: To keep watch for an event

29. Sentinel system was launched by FDA in -

Ans :- B: May 2008

30. Type of comparative observational studies is

Ans :- C: Cohort studies

31. Targeted clinical investigations required -

Ans :- B: FDA approval

32. This is the type of registry -

Ans :- A: Disease registry

33. Which of the following is false about prescription event monitoring (PEM) -

Ans :-B: PEM is expensive to set up

34. WHO-ART has:

Ans: A: 4 levels hierarchical structure

35. Which one is proper description of term “Benefit-risk analysis”?


Ans: B: Examination of the favourable and unfavourable results of undertaking a specific
course of action.

36. What is an Attributable risk?

Ans: D: Difference between the risk in an exposed population (absolute risk) and the risk in
an unexposed population (reference risk)

37. What is full form of MedDRA

Ans: A: Medical Dictionary for Regulatory Activities

38. PV tools not used by UMC are

Ans: D: VigiPassTM

39. Which one of the following is High level term?

Ans: A: Peptic ulcer

40. Which of the following define Cohort studies?

Ans. B: Studies that identify defined populations and follow them forward in time, examining
their rates of disease.

41. Define Solicited reports


Ans. A: Those derived from organized data collection systems, which include clinical trials,
registries, post-approval named patient use programs, other patient support and disease
management programs, surveys of patients or healthcare providers, or information gathering
on efficacy or patient compliance

42. Type C adverse drug reaction are


Ans: C: A dose- and time-related reaction

43. Type E adverse drug reaction is

Ans: A: A withdrawal reaction

44. ICH stands for –

ANS :- A: The International Council for Harmonisation of Technical Requirements for


Pharmaceuticals for Human Use

45. ICH guidelines E6 is for -

ANS :- A: Good Clinical Practice

46. CIOMS is based in –

ANS :- C:Geneva

47. To date, there are ___CIOMS working groups

ANS :- B: 8

48. CDSCO is located in __

ANS :- B: New Delhi

49. D& C act was passed in -

ANS :- D: 1940

50. Indian Pharmacovigilance system is regulated by -

ANS :- B: CDSCO

You might also like